FSGS and NS Research Funding Opportunities Through PRMRP
The US Department of Defense includes FSGS and nephrotic syndrome as two of the priority ...
ISGD President Tobias B. Huber Awarded Prestigious ERC Advanced Grant to Study FSGS
Professor Dr. Tobias B. Huber, the inaugural President of the International Society of ...
New Era Act Introduced in Congress
We are thrilled to share that the New Era of Preventing End-Stage Kidney Disease Act ...
Announcing the PARASOL Project: PROTEINURIA AND GFR AS CLINICAL TRIAL ENDPOINTS IN FOCAL SEGMENTAL GLOMERULOSCLEROSIS
ISGD is collaborating in a multidisciplinary effort to tackle the urgent problem of ...
EXPLORING THE NICHE: GLOMERULAR DISEASE MANAGEMENT IN NEPHROLOGY
Navigating the complexities of glomerular diseases (GD) in nephrology is no small feat. ...
Addressing the Unequal Burden of Kidney Disease on Black Americans
As kidney specialists, I'm sure we all know the statistic that chronic kidney disease is ...
The AFFINITY Study: Seeking 20 FSGS Patients
The AFFINITY study is a global, open-label, phase 2 basket trial evaluating the safety ...
Advocating with Congress for Rare Kidney Disease
I spent July 12 on Capitol Hill in Washington DC, logging over 4 miles as I walked ...
International Podocyte Conference Research Achievement Awards
The ISGD team extends our congratulations to the winners of the 14th International ...